Work

Maximal Tolerated Dose of the BCL-2 Inhibitor Venetoclax in Combination with Daunorubicin/Cytarabine Induction in Previously Untreated Adults with Acute Myeloid Leukemia (AML)

Year: 2020

Type: article

Study design: Clinical Trial

Source: Blood

DOI: 10.1182/blood-2020-140646

Authors: Richard M. Stone, Daniel J. DeAngelo, Anthony G. Letai, Jeremy M. Stewart, Michael McGinnis, Francis Brown, Geoffrey Fell, Yael Flammand, Marina Konopleva, Jacqueline S. Garcia, Marlise R Luskin

Institutions: Dana-Farber Cancer Institute, The University of Texas MD Anderson Cancer Center

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3094703295

FWCI: 1.704

Cites:

Cited by: 14

Related to: 10